Cargando…
ASGR1 - a new target for lowering non-HDL cholesterol
Non-HDL cholesterol (non-HDL-C) has been introduced as an alternative cardiovascular (CV) risk marker and a secondary therapeutic target in patients with combined hyperlipidemia, diabetes mellitus, metabolic syndrome, or chronic kidney disease. An important genetic study on the Icelandic population...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Magdi Yacoub Heart Foundation
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642823/ https://www.ncbi.nlm.nih.gov/pubmed/29043262 http://dx.doi.org/10.21542/gcsp.2016.14 |